INPP5J and hepatocellular carcinoma: INPP5J is a negative regulator for PI3K/AKT signaling and thus may function as a tumor suppressor, which was demonstrated in breast cancer [38], ovarian cancer [39], hepatocellular carcinoma [40], and oesophageal squamous cell carcinoma [41].